6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Emotional Triggers in Addiction Relapse
Emotional triggers such as stress, anxiety, and unresolved trauma play a critical role in addiction relapse. These triggers often evoke powerful memories associated with substance use, creating a cycle of emotional distress and cravings. For instance, feelings of loneliness or anger may push individuals to seek temporary relief through drugs or alcohol. Addressing these triggers requires a multi-faceted approach, including cognitive-behavioral therapy (CBT), mindfulness practices, and building strong support networks. Identifying emotional vulnerabilities and developing healthier coping mechanisms empowers individuals to break the cycle of relapse. Long-term recovery necessitates emotional resilience and proactive management of life’s challenges.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States